147 related articles for article (PubMed ID: 27529370)
1. KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma.
Manente AG; Pinton G; Zonca S; Tavian D; Habib T; Jithesh PV; Fennell D; Nilsson S; Moro L
Epigenomics; 2016 Sep; 8(9):1227-38. PubMed ID: 27529370
[TBL] [Abstract][Full Text] [Related]
2. Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells.
Manente AG; Pinton G; Zonca S; Cilli M; Rinaldi M; Daga A; Nilsson S; Moro L
Oncotarget; 2015 Sep; 6(28):25121-34. PubMed ID: 26208479
[TBL] [Abstract][Full Text] [Related]
3. Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma.
Cregan S; Breslin M; Roche G; Wennstedt S; MacDonagh L; Albadri C; Gao Y; O'Byrne KJ; Cuffe S; Finn SP; Gray SG
Int J Oncol; 2017 Mar; 50(3):1044-1052. PubMed ID: 28197626
[TBL] [Abstract][Full Text] [Related]
4. Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2α.
Guo X; Tian Z; Wang X; Pan S; Huang W; Shen Y; Gui Y; Duan X; Cai Z
Acta Biochim Biophys Sin (Shanghai); 2015 Feb; 47(2):106-13. PubMed ID: 25520177
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells.
Pinton G; Zonca S; Manente AG; Cavaletto M; Borroni E; Daga A; Jithesh PV; Fennell D; Nilsson S; Moro L
Oncotarget; 2016 Mar; 7(12):14366-79. PubMed ID: 26885609
[TBL] [Abstract][Full Text] [Related]
6. Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity.
Pinton G; Manente AG; Daga A; Cilli M; Rinaldi M; Nilsson S; Moro L
Mol Cancer; 2014 Oct; 13():227. PubMed ID: 25277603
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib.
Pinton G; Thomas W; Bellini P; Manente AG; Favoni RE; Harvey BJ; Mutti L; Moro L
PLoS One; 2010 Nov; 5(11):e14110. PubMed ID: 21124760
[TBL] [Abstract][Full Text] [Related]
8. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3.
Prickaerts P; Adriaens ME; Beucken TVD; Koch E; Dubois L; Dahlmans VEH; Gits C; Evelo CTA; Chan-Seng-Yue M; Wouters BG; Voncken JW
Epigenetics Chromatin; 2016; 9():46. PubMed ID: 27800026
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-Mediated Regulation of Histone Demethylases Affects Angiogenesis-Associated Functions in Endothelial Cells.
Liu OH; Kiema M; Beter M; Ylä-Herttuala S; Laakkonen JP; Kaikkonen MU
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2665-2677. PubMed ID: 32938217
[TBL] [Abstract][Full Text] [Related]
11. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.
Cheng YY; Kirschner MB; Cheng NC; Gattani S; Klebe S; Edelman JJ; Vallely MP; McCaughan BC; Jin HC; van Zandwijk N; Reid G
J Thorac Oncol; 2013 Oct; 8(10):1317-28. PubMed ID: 24457242
[TBL] [Abstract][Full Text] [Related]
12. Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma.
Bensaid D; Blondy T; Deshayes S; Dehame V; Bertrand P; Grégoire M; Errami M; Blanquart C
Clin Epigenetics; 2018; 10():79. PubMed ID: 29946373
[TBL] [Abstract][Full Text] [Related]
13. Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma.
Andersen M; Trapani D; Ravn J; Sørensen JB; Andersen CB; Grauslund M; Santoni-Rugiu E
Anticancer Res; 2015 Nov; 35(11):6223-9. PubMed ID: 26504055
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase KDM6B regulates human podocyte differentiation
Guo Y; Xiong Z; Guo X
Biochem J; 2019 Jun; 476(12):1741-1751. PubMed ID: 31138771
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of the histone demethylase KDM6B in alcohol dependence is associated with epigenetic regulation of inflammatory signaling pathways.
Johnstone AL; Andrade NS; Barbier E; Khomtchouk BB; Rienas CA; Lowe K; Van Booven DJ; Domi E; Esanov R; Vilca S; Tapocik JD; Rodriguez K; Maryanski D; Keogh MC; Meinhardt MW; Sommer WH; Heilig M; Zeier Z; Wahlestedt C
Addict Biol; 2021 Jan; 26(1):e12816. PubMed ID: 31373129
[TBL] [Abstract][Full Text] [Related]
17. Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia.
Zonca S; Pinton G; Wang Z; Soluri MF; Tavian D; Griffin M; Sblattero D; Moro L
Cell Death Dis; 2017 Feb; 8(2):e2592. PubMed ID: 28151477
[TBL] [Abstract][Full Text] [Related]
18. The involvement of histone methylation in osteoblastic differentiation of human periosteum-derived cells cultured in vitro under hypoxic conditions.
Yoon DK; Park JS; Rho GJ; Lee HJ; Sung IY; Son JH; Park BW; Kang YH; Byun SH; Hwang SC; Woo DK; Cho YC; Byun JH
Cell Biochem Funct; 2017 Oct; 35(7):441-452. PubMed ID: 29082591
[TBL] [Abstract][Full Text] [Related]
19. KDM6B Elicits Cell Apoptosis by Promoting Nuclear Translocation of FOXO1 in Non-Small Cell Lung Cancer.
Ma J; Wang N; Zhang Y; Wang C; Ge T; Jin H; Deng X; Huo X; Gu D; Ge Z; Chu W; Jiang L; Qin W
Cell Physiol Biochem; 2015; 37(1):201-13. PubMed ID: 26303949
[TBL] [Abstract][Full Text] [Related]
20. A Succinate Ether Derivative of Tocotrienol Enhances Dickkopf-1 Gene Expression through Epigenetic Alterations in Malignant Mesothelioma Cells.
Sato A; Ueno H; Fusegi M; Kaneko S; Kohno K; Virgona N; Ando A; Sekine Y; Yano T
Pharmacology; 2018; 102(1-2):26-36. PubMed ID: 29763912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
